Cassia Cearley, Chief Business Officer at Icosavax, Inc. (ICVX), sold 1,660 shares at $10.69 ($18K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Scheduled sale ($18k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICVX | SELL | 2023-08-01 | $17K | — | Filing → |
| ICVX | SELL | 2023-05-25 | $100K | — | Filing → |
| ICVX | SELL | 2023-03-08 | $39K | — | Filing → |